Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

real-time data

- PMLiVE

Medscape To Bring Leading Cardiology Education to ESC

The Medscape Global team is bringing their leading cardiology education and proven impact to the European Society of Cardiology (ESC) Congress in Madrid for 2025. Powered by enhanced technologies, methodologies,...

Medscape Education

- PMLiVE

MSD receives NICE recommendation for Keytruda in advanced endometrial cancer

More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK

- PMLiVE

Novo Nordisk appoints Maziar Mike Doustdar as president and CEO

Doustdar has most recently been serving as Novo’s executive vice president of international operations

- PMLiVE

Maximising impact in medical communications: where are we now and where are we heading?

By Ben Holtom

Engage Internal Teams Virtually – Engaging Your Advisors Creatively

Boost internal effectiveness! Learn a creative way to use virtual advisory boards to facilitate best practice-sharing with sales representatives and knowledge-sharing with MSLs. This is the key to aligning your...

Impetus Digital

- PMLiVE

The Mission to Humanize Healthcare

Medical and scientific innovation are in a fast lane closely pursued by digital advances but their dynamism can mute a vital element of progressive healthcare – patient integration.

Medscape Education

- PMLiVE

Roche’s Evrysdi tablets approved by MHRA to treat spinal muscular atrophy

It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version

- PMLiVE

Apogee Therapeutics’ atopic dermatitis candidate shows promise in phase 2 study

The inflammatory skin condition affects over 26 million people in the US

- PMLiVE

Empower or fall behind: why true patient engagement is pharma’s competitive edge

By Paul Allen

market access in Japan

Implementation of Cost-Effectiveness Analysis in Japan’s Health Technology Assessment Process

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new medicines and medical devices. Introduced as part of a broader health technology assessment (HTA)...

Petauri Evidence

- PMLiVE

AstraZeneca’s Imfinzi/Imjudo regimen recommended by NICE to treat liver cancer

Approximately 6,600 people are diagnosed with liver cancer every year in the UK

- PMLiVE

Eli Lilly shares positive results for Jaypirca in head-to-head CLL/SLL study

Around 23,690 cases of chronic lymphocytic leukaemia are expected to be diagnosed in the US this year

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links